Improving breast and cervical cancer screening in Kenya
Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11403676
This project partners with Kenyan hospitals, clinics, and communities to make it easier for people to get breast and cervical cancer screening and timely follow-up care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11403676 on ClinicalTrials.gov |
What this research studies
From my perspective as someone in Kenya, the BREAKTHROUGH Center brings together hospitals, universities, and community groups to close gaps in cancer screening and treatment. They will run two linked research projects plus training programs, and use an administrative and engagement core to work with local clinics and government partners. The work focuses on practical changes like staff training, outreach, and better systems for screening and follow-up at participating sites. The aim is to make proven screening methods part of routine care so cancers are found earlier and treated sooner.
Who could benefit from this research
Good fit: Women in Kenya who are eligible for breast or cervical cancer screening—including those living with HIV—and people who can attend participating clinics are the main candidates.
Not a fit: People who live outside Kenya, men who are not at risk for these cancers, or patients already under advanced cancer treatment may not benefit directly from this screening-focused work.
Why it matters
Potential benefit: If successful, more people could be screened earlier, catch cancers at treatable stages, and get faster access to care.
How similar studies have performed: Screening programs have lowered cancer deaths in well-resourced settings, but sustainably delivering and scaling these programs in Kenya is less tested and is what this center aims to address.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHUNG, MICHAEL HOONBAE — EMORY UNIVERSITY
- Study coordinator: CHUNG, MICHAEL HOONBAE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Advanced Cancer